Product

Safusidenib

1 clinical trial

1 indication

Indication
Glioma
Clinical trial
A Phase 0/2 Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma
Status: Recruiting, Estimated PCD: 2024-12-01